terbinafine hydrochloride
- Product NDC
- 68071-2426
- 11-digit product format
- 680712426
- Labeler code
- 68071
- Product ID
- 68071-2426_c365c50e-cff9-116e-e053-2995a90ae0ff
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- terbinafine hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA078163
- Marketing category
- ANDA
- Marketing start
- 2020-10-01
- Marketing end
- 0000-00-00
- Substance
- TERBINAFINE HYDROCHLORIDE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Allylamine [CS],Allylamine Antifungal [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-2426 | TERBINAFINE HYDROCHLORIDE TABLET [NUCARE PHARMACEUTICALS,INC.] | 1 | Legacy NDC | 20210529_c365c50e-cff8-116e-e053-2995a90ae0ff.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-2426-3 | 68071242603 | 30 TABLET in 1 BOTTLE, PLASTIC (68071-2426-3) | 30 tablet | 2021-05-28 | 0000-00-00 | No | No | Current |